P77 Prevalence and Risk Factors of Hepatitis C Among Individuals Presenting to HIV Testing Centers, Hawassa City, Southern Ethiopia

Tuesday, March 13, 2012
Hyatt Exhibit Hall
Addisu Alemayehu, MSc1, Yayehyirad Tassachew, MSc1, Zufan Sisay, MSc2 and Techalew Shimelis, MSc1, 1Medical Laboratory Science, Hawassa University, Hawassa, Ethiopia, 2Aklilu Lemma Institute of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia

Background: Hepatitis C virus (HCV), either alone or in combination with Human Immunodeficiency virus (HIV), constitutes a major public health concern. However, information is scarce regarding the rate of HIV-HCV co-infection in Ethiopia where HIV is prevalent.

Objectives:This study was conducted to describe the prevalence and risk factors for HCV infection in people with and without HIV infection.

Methods:Blood samples and data on socio-demographic and risk factors for HCV infection were collected from consecutive 400 HIV- positive and 400 HIV- negative individuals attending HIV testing centers in Hawassa city, from October to December, 2008. All sera were tested for antibody to HCV infection (anti-HCV) using enzyme linked immunosorbent assay (ELISA). Sera positive for anti-HCV were further tested for viral ribonucleic acid (RNA) levels using real-time polymerase chain reaction.

Results: The rate of anti-HCV positivity was 10.5% in the HIV- infected individuals compared with 6% in the HIV negative group (p = 0.002). HCV-RNA was detected in 9.1% of anti-HCV positive samples and rates were comparable between HIV- infected and HIV- non-infected individuals. There was no significant difference in odds of HCV infection in participants with and without HCV risk factors in either HIV sero-group.

Conclusions: HIV infected individuals had significantly higher rate of anti-HCV although most of them showed no evidence of viraemia.

Implications for Programs, Policy, and Research: While priority should be given for HIV infected patients, testing those with anti-HCV for HCV-RNA remains important.